Medicamen Biotech Limited (MEDICAMEQ) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.018x

Based on the latest financial reports, Medicamen Biotech Limited (MEDICAMEQ) has a cash flow conversion efficiency ratio of 0.018x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs36.46 Million ≈ $394.32K USD) by net assets (Rs2.00 Billion ≈ $21.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MEDICAMEQ net asset quality index to measure how much of total assets are equity-financed.

Medicamen Biotech Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Medicamen Biotech Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Medicamen Biotech Limited (MEDICAMEQ) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Medicamen Biotech Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medicamen Biotech Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Wisr Ltd
AU:WZR
0.105x
PetVivo Holdings Inc
NASDAQ:PETV
-0.438x
Seafresh Industry Public Company Limited
BK:CFRESH
0.070x
Cemat A/S
CO:CEMAT
0.066x
Big Camera Corporation Public Company Limited
BK:BIG
-0.016x
Tracxn Technologies Limited
NSE:TRACXN
0.019x
Atara Biotherapeutics Inc
NASDAQ:ATRA
0.267x
5TH PLANET GAMES DK -50
F:2HG1
-0.012x

Annual Cash Flow Conversion Efficiency for Medicamen Biotech Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Medicamen Biotech Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Medicamen Biotech Limited market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs2.13 Billion
≈ $23.01 Million
Rs-98.59 Million
≈ $-1.07 Million
-0.046x -42.21%
2024-03-31 Rs2.07 Billion
≈ $22.38 Million
Rs-67.44 Million
≈ $-729.32K
-0.033x -0.14%
2023-03-31 Rs1.93 Billion
≈ $20.92 Million
Rs-62.93 Million
≈ $-680.54K
-0.033x -215.97%
2022-03-31 Rs1.46 Billion
≈ $15.84 Million
Rs41.09 Million
≈ $444.38K
0.028x -70.81%
2021-03-31 Rs1.33 Billion
≈ $14.37 Million
Rs127.72 Million
≈ $1.38 Million
0.096x -9.00%
2020-03-31 Rs1.21 Billion
≈ $13.11 Million
Rs128.02 Million
≈ $1.38 Million
0.106x +112.74%
2019-03-31 Rs866.34 Million
≈ $9.37 Million
Rs43.01 Million
≈ $465.12K
0.050x +167.91%
2018-03-31 Rs746.08 Million
≈ $8.07 Million
Rs-54.54 Million
≈ $-589.80K
-0.073x -154.50%
2017-03-31 Rs267.81 Million
≈ $2.90 Million
Rs35.92 Million
≈ $388.49K
0.134x -61.29%
2016-03-31 Rs179.09 Million
≈ $1.94 Million
Rs62.06 Million
≈ $671.13K
0.347x +281.86%
2015-03-31 Rs171.85 Million
≈ $1.86 Million
Rs-32.74 Million
≈ $-354.11K
-0.191x -161.32%
2014-03-31 Rs165.38 Million
≈ $1.79 Million
Rs51.39 Million
≈ $555.74K
0.311x +410.42%
2013-03-31 Rs157.17 Million
≈ $1.70 Million
Rs-15.73 Million
≈ $-170.14K
-0.100x +42.34%
2012-03-31 Rs201.01 Million
≈ $2.17 Million
Rs-34.90 Million
≈ $-377.38K
-0.174x -131.21%
2011-03-31 Rs204.12 Million
≈ $2.21 Million
Rs113.52 Million
≈ $1.23 Million
0.556x +722.44%
2010-03-31 Rs162.61 Million
≈ $1.76 Million
Rs11.00 Million
≈ $118.92K
0.068x -89.45%
2009-03-31 Rs129.60 Million
≈ $1.40 Million
Rs83.07 Million
≈ $898.33K
0.641x +227.09%
2008-03-31 Rs115.83 Million
≈ $1.25 Million
Rs22.70 Million
≈ $245.46K
0.196x +662.67%
2007-03-31 Rs100.73 Million
≈ $1.09 Million
Rs2.59 Million
≈ $27.99K
0.026x -91.54%
2006-03-31 Rs85.67 Million
≈ $926.49K
Rs26.02 Million
≈ $281.45K
0.304x --

About Medicamen Biotech Limited

NSE:MEDICAMEQ India Drug Manufacturers - Specialty & Generic
Market Cap
$35.21 Million
Rs3.26 Billion INR
Market Cap Rank
#23151 Global
#1287 in India
Share Price
Rs240.02
Change (1 day)
+2.33%
52-Week Range
Rs223.30 - Rs415.95
All Time High
Rs1195.88
About

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-… Read more